# Convalescent Plasma Therapy in Severe COVID-19 Infection

> **NCT04403477** · PHASE2 · UNKNOWN · sponsor: **Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh** · enrollment: 20 (estimated)

## Conditions studied

- Covid19
- Convalescence

## Interventions

- **BIOLOGICAL:** Convalescent plasma

## Key facts

- **NCT ID:** NCT04403477
- **Lead sponsor:** Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-05-20
- **Primary completion:** 2020-07-20
- **Final completion:** 2020-10-30
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2020-05-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04403477

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04403477, "Convalescent Plasma Therapy in Severe COVID-19 Infection". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04403477. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*